363 related articles for article (PubMed ID: 24780245)
1. Updates of reactive oxygen species in melanoma etiology and progression.
Liu-Smith F; Dellinger R; Meyskens FL
Arch Biochem Biophys; 2014 Dec; 563():51-5. PubMed ID: 24780245
[TBL] [Abstract][Full Text] [Related]
2. NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.
Weyemi U; Redon CE; Parekh PR; Dupuy C; Bonner WM
Anticancer Agents Med Chem; 2013 Mar; 13(3):502-14. PubMed ID: 22931418
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue.
Rouaud F; Romero-Perez M; Wang H; Lobysheva I; Ramassamy B; Henry E; Tauc P; Giacchero D; Boucher JL; Deprez E; Rocchi S; Slama-Schwok A
Oncotarget; 2014 Nov; 5(21):10650-64. PubMed ID: 25296975
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
5. NOX Inhibitors: From Bench to Naxibs to Bedside.
Elbatreek MH; Mucke H; Schmidt HHHW
Handb Exp Pharmacol; 2021; 264():145-168. PubMed ID: 32780287
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.
Kawahara T; Ritsick D; Cheng G; Lambeth JD
J Biol Chem; 2005 Sep; 280(36):31859-69. PubMed ID: 15994299
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence.
Tsai IC; Pan ZC; Cheng HP; Liu CH; Lin BT; Jiang MJ
J Mol Cell Cardiol; 2016 Sep; 98():18-27. PubMed ID: 27381955
[TBL] [Abstract][Full Text] [Related]
8. Redox regulation of Nox proteins.
Pendyala S; Natarajan V
Respir Physiol Neurobiol; 2010 Dec; 174(3):265-71. PubMed ID: 20883826
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.
Rezende F; Prior KK; Löwe O; Wittig I; Strecker V; Moll F; Helfinger V; Schnütgen F; Kurrle N; Wempe F; Walter M; Zukunft S; Luck B; Fleming I; Weissmann N; Brandes RP; Schröder K
Free Radic Biol Med; 2017 Jan; 102():57-66. PubMed ID: 27863990
[TBL] [Abstract][Full Text] [Related]
10. Mammalian NADPH Oxidases.
Buvelot H; Jaquet V; Krause KH
Methods Mol Biol; 2019; 1982():17-36. PubMed ID: 31172464
[TBL] [Abstract][Full Text] [Related]
11. NADPH oxidase 4 is an oncoprotein localized to mitochondria.
Graham KA; Kulawiec M; Owens KM; Li X; Desouki MM; Chandra D; Singh KK
Cancer Biol Ther; 2010 Aug; 10(3):223-31. PubMed ID: 20523116
[TBL] [Abstract][Full Text] [Related]
12. An NAD(P)H oxidase regulates growth and transcription in melanoma cells.
Brar SS; Kennedy TP; Sturrock AB; Huecksteadt TP; Quinn MT; Whorton AR; Hoidal JR
Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1212-24. PubMed ID: 11997235
[TBL] [Abstract][Full Text] [Related]
13. NOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm.
Dickson BJ; Gatie MI; Spice DM; Kelly GM
PLoS One; 2017; 12(2):e0170812. PubMed ID: 28152080
[TBL] [Abstract][Full Text] [Related]
14. Amyloids, melanins and oxidative stress in melanomagenesis.
Liu-Smith F; Poe C; Farmer PJ; Meyskens FL
Exp Dermatol; 2015 Mar; 24(3):171-4. PubMed ID: 25271672
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights of NADPH oxidases and its pathological consequences.
Waghela BN; Vaidya FU; Agrawal Y; Santra MK; Mishra V; Pathak C
Cell Biochem Funct; 2021 Mar; 39(2):218-234. PubMed ID: 32975319
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the Activity of NADPH Oxidase in Cancer.
Konaté MM; Antony S; Doroshow JH
Antioxid Redox Signal; 2020 Aug; 33(6):435-454. PubMed ID: 32008376
[No Abstract] [Full Text] [Related]
17. Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation.
Dao VT; Elbatreek MH; Altenhöfer S; Casas AI; Pachado MP; Neullens CT; Knaus UG; Schmidt HHHW
Free Radic Biol Med; 2020 Feb; 148():60-69. PubMed ID: 31883469
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes.
Han CY; Umemoto T; Omer M; Den Hartigh LJ; Chiba T; LeBoeuf R; Buller CL; Sweet IR; Pennathur S; Abel ED; Chait A
J Biol Chem; 2012 Mar; 287(13):10379-10393. PubMed ID: 22287546
[TBL] [Abstract][Full Text] [Related]
19. NOX Dependent ROS Generation and Cell Metabolism.
Pecchillo Cimmino T; Ammendola R; Cattaneo F; Esposito G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768405
[TBL] [Abstract][Full Text] [Related]
20. The Nox family of NADPH oxidases: friend or foe of the vascular system?
Takac I; Schröder K; Brandes RP
Curr Hypertens Rep; 2012 Feb; 14(1):70-8. PubMed ID: 22071588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
